Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing

Translational Research

Volumn 168, Issue , 2016, Pages 22-39

  Pouladi, Nima ^a,b   Bime, Christian ^c   Garcia, Joe G N ^c   Lussier, Yves A ^a,b,c,d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; DNA;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE PREDISPOSITION; DNA SEQUENCE; ENDOPHENOTYPE; FIBROSING ALVEOLITIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LUNG DISEASE; LUNG GRANULOMATOSIS; METAGENOME; METAGENOMICS; MICROBIOME; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY; TREATMENT RESPONSE; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG DISEASES; SEQUENCE ANALYSIS, DNA;

EID: 84930898953     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.04.016     Document Type: Review

References (93)

1. 1 Hindorff, L.A., Sethupathy, P., Junkins, H.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106 (2009), 9362–9367.
2. 2 National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3)—Guidelines for the Diagnosis and Management of Asthma, Summary Report 2007. J Allergy Clin Immunol 120:5 suppl 1 (2007), S94–S138.
3. 3 Moorman, J.E., Rudd, R.A., Johnson, C.A., et al. National surveillance for asthma—United States 1980-2004. Morbidity and Mortality Weekly Report 56 (2007), 1–54.
4. 4 Moorman, J.E., Mannino, D.M., Increasing U.S. asthma mortality rates: who is really dying?. J Asthma 38 (2001), 65–71.
5. 5 Moorman, J.E., Akinbami, L.J., Bailey, C.M., et al. National surveillance of asthma: United States 2001-2010. National Center for Health Statistics. Vital Health Stat 3:35 (2012), 1–67.
6. 6 Eder, W., Ege, M.J., von Mutius, E., The asthma epidemic. N Engl J Med 355 (2006), 2226–2235.
7. 7 Duffy, D.L., Martin, N.G., Battistutta, D., Hopper, J.L., Mathews, J.D., Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 142:6 Pt 1 (1990), 1351–1358.
8. 8 Moffatt, M.F., Kabesch, M., Liang, L., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448 (2007), 470–473.
9. 9 Galanter, J.M., Gignoux, C.R., Torgerson, D.G., et al. Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans study. J Allergy Clin Immunol 134 (2014), 295–305.
10. 10 Ferreira, M.A., Matheson, M.C., Tang, C.S., et al. Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J Allergy Clin Immunol 133 (2014), 1564–1571.
11. 11 Bønnelykke, K., Sleiman, P., Nielsen, K., et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 46 (2014), 51–55.
12. 12 Lasky-Su, J., Himes, B., Raby, B., et al. HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. Clin Exp Allergy 42 (2012), 1724–1733.
13. 13 Li, X., Ampleford, E.J., Howard, T.D., et al. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol 130 (2012), 861–868.
14. 14 Wan, Y., Shrine, N., Artigas, M.S., et al. Genome-wide association study to identify genetic determinants of severe asthma. Thorax 67 (2012), 762–768.
15. 15 Anantharaman, R., Andiappan, A.K., Nilkanth, P.P., Suri, B.K., Wang, D.Y., Chew, F.T., Genome-wide association study identifies PERLD1 as asthma candidate gene. BMC Med Genet, 12, 2011, 170.
16. 16 Ferreira, M.A., Matheson, M.C., Duffy, D.L., et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet 378 (2011), 1006–1014.
17. 17 Hirota, T., Takahashi, A., Kubo, M., et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 43 (2011), 893–896.
18. 18 Torgerson, D.G., Ampleford, E.J., Chiu, G.Y., et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 43 (2011), 887–892.
19. 19 Noguchi, E., Sakamoto, H., Hirota, T., et al. Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet, 7, 2011, e1002170.
20. 20 Ferreira, M.A., McRae, A.F., Medland, S.E., et al. Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia. Eur J Hum Genet 19 (2010), 458–464.
21. 21 Moffatt, M.F., Gut, I.G., Demenais, F., et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363 (2010), 1211–1221.
22. 22 Sleiman, P.M., Flory, J., Imielinski, M., et al. Variants of DENND1B associated with asthma in children. N Engl J Med 362 (2010), 36–44.
23. 23 Castro-Giner, F., Bustamante, M., González, J.R., et al. A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS). BMC Med Genet, 10, 2009, 128.
24. 24 Himes, B.E., Hunninghake, G.M., Baurley, J.W., et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 84 (2009), 581–593.
25. 25 DeWan, A.T., Triche, E.W., Xu, X., et al. PDE11A associations with asthma: results of a genome-wide association scan. J Allergy Clin Immunol 126 (2010), 871–873.
26. 26 Gudbjartsson, D.F., Bjornsdottir, U.S., Halapi, E., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41 (2009), 342–347.
27. 27 Imboden, M., Bouzigon, E., Curjuric, I., et al. Genome-wide association study of lung function decline in adults with and without asthma. J Allergy Clin Immunol 129 (2012), 1218–1228.
28. 28 Ober, C., Tan, Z., Sun, Y., et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 358 (2008), 1682–1691.
29. 29 Park, B.L., Kim, T.-H., Kim, J.-H., et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet 132 (2013), 313–321.
30. 30 Wu, A.C., Himes, B.E., Lasky-Su, J., et al. Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics. J Allergy Clin Immunol 133 (2014), 723–728.
31. 31 Tantisira, K.G., Damask, A., Szefler, S.J., et al. Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus. Am J Respir Crit Care Med 185 (2012), 1286–1291.
32. 32 Tantisira, K.G., Lasky-Su, J., Harada, M., et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 365 (2011), 1173–1183.
33. 33 Drazen, J.M., Silverman, E.K., Lee, T.H., Heterogeneity of therapeutic responses in asthma. Br Med Bull 56 (2000), 1054–1070.
34. 34 Barnes, P., Celli, B., Systemic manifestations and comorbidities of COPD. Eur Respir J 33 (2009), 1165–1185.
35. 35 Berndt, A., Leme, A.S., Shapiro, S.D., Emerging genetics of COPD. EMBO Mol Med 4 (2012), 1144–1155.
36. 36 Salvi, S.S., Barnes, P.J., Chronic obstructive pulmonary disease in non-smokers. Lancet 374 (2009), 733–743.
37. 37 Shaykhiev, R., Crystal, R.G., Early events in the pathogenesis of chronic obstructive pulmonary disease. smoking-induced reprogramming of airway epithelial basal progenitor cells. Ann Am Thorac Soc 11:suppl 5 (2014), S252–S258.
38. 38 Todd, J.L., Goldstein, D.B., Ge, D., Christie, J., Palmer, S.M., The state of genome-wide association studies in pulmonary disease: a new perspective. Am J Respir Crit Care Med 184 (2011), 873–880.
39. 39 Cho, M.H., McDonald, M.L., Zhou, X., et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med 2 (2014), 214–225.
40. 40 Manichaikul, A., Hoffman, E.A., Smolonska, J., et al. Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med 189 (2014), 408–418.
41. 41 Cho, M.H., Castaldi, P.J., Wan, E.S., et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 21 (2012), 947–957.
42. 42 Wan, E.S., Cho, M.H., Boutaoui, N., et al. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 45 (2011), 304–310.
43. 43 Cho, M.H., Boutaoui, N., Klanderman, B.J., et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42 (2010), 200–202.
44. 44 Pillai, S.G., Ge, D., Zhu, G., et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet, 5, 2009, e1000421.
45. 45 Siedlinski, M., Cho, M.H., Bakke, P., et al. Genome-wide association study of smoking behaviours in patients with COPD. Thorax 66 (2011), 894–902.
46. 46 Hao, K., Bossé, Y., Nickle, D.C., et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet, 8, 2012, e1003029.
47. 47 Noth, I., Zhang, Y., Ma, S.-F., et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med 1 (2013), 309–317.
48. 48 Fingerlin, T.E., Murphy, E., Zhang, W., et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 45 (2013), 613–620.
49. 49 Mushiroda, T., Wattanapokayakit, S., Takahashi, A., et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 45 (2008), 654–656.
50. 50 Hofmann, S., Fischer, A., Nothnagel, M., et al. Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis. Eur Respir J 41 (2013), 888–900.
51. 51 Fischer, A., Schmid, B., Ellinghaus, D., et al. A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1. Am J Respir Crit Care Med 186 (2012), 877–885.
52. 52 Hofmann, S., Fischer, A., Till, A., et al. A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J 38 (2011), 1127–1135.
53. 53 Hofmann, S., Franke, A., Fischer, A., et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 40 (2008), 1103–1106.
54. 54 Franke, A., Fischer, A., Nothnagel, M., et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 135 (2008), 1207–1215.
55. 55 Artigas, M.S., Loth, D.W., Wain, L.V., et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43 (2011), 1082–1090.
56. 56 Travis, W.D., Costabel, U., Hansell, D.M., et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 (2013), 733–748.
57. 57 Zibrak, J.D., Price, D., Interstitial lung disease: raising the index of suspicion in primary care. NPJ Prim Care Respir Med, 24, 2014, 14054.
58. 58 Germain, M., Eyries, M., Montani, D., et al. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet 45 (2013), 518–521.
59. 59 Hadchouel, A., Durrmeyer, X., Bouzigon, E., et al. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med 184 (2011), 1164–1170.
60. 60 Zhang, Y., Noth, I., Garcia, J.G., Kaminski, N., A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 364 (2011), 1576–1577.
61. 61 Spagnolo, P., Grunewald, J., Recent advances in the genetics of sarcoidosis. J Med Genet 50 (2013), 290–297.
62. 62 Baraldi, E., Filippone, M., Chronic lung disease after premature birth. N Engl J Med 357 (2007), 1946–1955.
63. 63 Walsh, M.C., Szefler, S., Davis, J., et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 117:suppl 1 (2006), S52–S56.
64. 64 Lavoie, P.M., Pham, C., Jang, K.L., Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 122 (2008), 479–485.
65. 65 Wang, H., Julien, K.R.S., Stevenson, D.K., et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics 132 (2013), 290–297.
66. 66 Liu, D., Morrell, N.W., Genetics and the molecular pathogenesis of pulmonary arterial hypertension. Curr Hypertens Rep 15 (2013), 632–637.
67. 67 McLaughlin, V.V., McGoon, M.D., Pulmonary arterial hypertension. Circulation 114 (2006), 1417–1431.
68. 68 Simonneau, G., Gatzoulis, M.A., Adatia, I., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:25 suppl (2013), D34–D41.
69. 69 Schork, N.J., Murray, S.S., Frazer, K.A., Topol, E.J., Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19 (2009), 212–219.
70. 70 DeWan, A.T., Egan, K.B., Hellenbrand, K., et al. Whole-exome sequencing of a pedigree segregating asthma. BMC Med Genet, 13, 2012, 95.
71. 71 Campbell, C.D., Mohajeri, K., Malig, M., et al. Whole-genome sequencing of individuals from a founder population identifies candidate genes for asthma. PLoS One, 9, 2014, e104396.
72. 72 Wain, L.V., Sayers, I., Artigas, M.S., et al. Whole exome re-sequencing implicates CCDC38 and cilia structure and function in resistance to smoking related airflow obstruction. PLoS Genet, 10, 2014, e1004314.
73. 73 Austin, E.D., Ma, L., LeDuc, C., et al. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet 5 (2012), 336–343.
74. 74 Ma, L., Roman-Campos, D., Austin, E.D., et al. A novel channelopathy in pulmonary arterial hypertension. N Engl J Med 369 (2013), 351–361.
75. 75 De Jesus Perez, V.A., Yuan, K., Lyuksyutova, M.A., et al. Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 189 (2014), 1260–1272.
76. 76 Shortt, K., Chaudhary, S., Grigoryev, D., et al. Identification of novel single nucleotide polymorphisms associated with acute respiratory distress syndrome by exome-seq. PLoS One, 9, 2014, e111953.
77. 77 Dannemiller, K.C., Mendell, M.J., Macher, J.M., et al. Next-generation DNA sequencing reveals that low fungal diversity in house dust is associated with childhood asthma development. Indoor Air 24 (2014), 236–247.
78. 78 Park, H., Shin, J.W., Park, S.-G., Kim, W., Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PLoS One, 9, 2014, e109710.
79. 79 Garzoni, C., Brugger, S.D., Qi, W., et al. Microbial communities in the respiratory tract of patients with interstitial lung disease. Thorax 68 (2013), 1150–1156.
80. 80 Han, M.K., Zhou, Y., Murray, S., et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respir Med 2 (2014), 548–556.
81. 81 Manolio, T.A., Collins, F.S., Cox, N.J., et al. Finding the missing heritability of complex diseases. Nature 461 (2009), 747–753.
82. 82 Maher, B., The case of the missing heritability. Nature 456 (2008), 18–21.
83. 83 ENCODE Project Consortium. The ENCODE (ENCyclopedia of DNA elements) Project. Science 306 (2004), 636–640.
84. 84 Sanyal, A., Lajoie, B.R., Jain, G., Dekker, J., The long-range interaction landscape of gene promoters. Nature 489 (2012), 109–113.
85. 85 Lee, Y., Li, H., Li, J., et al. Network models of genome-wide association studies uncover the topological centrality of protein interactions in complex diseases. J Am Med Inform Assoc 20 (2013), 619–629.
86. 86 Nicolae, D.L., Gamazon, E., Zhang, W., Duan, S., Dolan, M.E., Cox, N.J., Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet, 6, 2010, e1000888.
87. 87 Ortega, V.E., Meyers, D.A., Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol 133 (2014), 16–26.
88. 88 Rumpel, J.A., Ahmedani, B.K., Peterson, E.L., et al. Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma. J Allergy Clin Immunol 130 (2012), 1302–1306.
89. 89 Rose, D., Mannino, D.M., Leaderer, B.P., Asthma prevalence among US adults, 1998–2000: role of Puerto Rican ethnicity and behavioral and geographic factors. Am J Public Health 96 (2006), 880–888.
90. 90 Salari, K., Burchard, E.G., Latino populations: a unique opportunity for epidemiological research of asthma. Paediatr Perinat Epidemiol 21:suppl 3 (2007), 15–22.
91. 91 Choudhry, S., Burchard, E.G., Borrell, L.N., et al. Ancestry–environment interactions and asthma risk among Puerto Ricans. Am J Respir Crit Care Med 174 (2006), 1088–1093.
92. 92 Moorman, J.E., Person, C.J., Zahran, H.S., Centers for Disease Control and Prevention (CDC). Asthma attacks among persons with current asthma—United States. MMWR Surveill Summ 62:suppl 3 (2013), 93–98.
93. 93 Kolb, M., Collard, H.R., Staging of idiopathic pulmonary fibrosis: past, present and future. Eur Respir Rev 23 (2014), 220–224.